Dr. Bobby George

VP Head Regulatory Affairs

Reliance Life Sciences

Heading Regulatory Aff airs with overall responsibility for regulatory services across all divisions at RLS (Pharmaceuticals, Biopharmaceuticals, Clinical research, Preclinical research, Molecular medicine, Regenerative Medicine & Cor blood banking) in both domestic and export (developed & emerging) markets.

• RLS Pharmaceutical division is focused on working on both the APIs and formulations in oncology.
• RLS Biopharmaceutical division is focused on working in the area of Biosimilars (several of which are from oncology domain), Plasma proteins and Novel proteins.
• RLS Clinical research division offers services in the area of Phase I, BA/BE studies, Phase II – IV trials both for in house products as well as for external clients.
• RLS Molecular medicine division offers services in the area of Molecular Microbiology; Cytogenetics & Molecular Genetics; Flow Cytometry; Anatomic Pathology and Cytopathology; Predictive Diagnostics and Pharmacogenomics.
• RLS Regenerative Medicine division is working towards developing a wide range of novel research-led, autologous and allogeneic cell therapies and tissue engineered products.
• RLS Cord Blood Repository offers both public and family banking services, which is used for transplantation.